Company: TXG
Filing Date: 2025-02-13
Form Type: 10-K
Source: 0001770787-25-000013
Chunk: 31

Company: 10x Genomics, Inc.
Filing Date: 2025-02-13
Form: 10-K
Item: Item 1A
Chunk 31
---
Doing business internationally, including in China and elsewhere in the Asia-Pacific region, and exposure to interest and foreign currency exchange rates;

•The ability of suppliers to meet our needs and the needs of our customers;

•The complexity of our operations and manufacturing our products, including in sourcing raw materials and preventing errors and defects in our solutions;

•Our limited operating history, losses since inception, fluctuations in revenue and management of growth; and

•The success of our products in achieving and sustaining scientific acceptance and generating revenue.

Risks related to our regulatory environment and taxation:

•Our products could become subject to more onerous government regulation; 

•Changes in tax laws or regulations that are applied adversely to us or our customers; and

•Ethical, legal, privacy and social concerns or governmental restrictions surrounding the use of the genomic and multiomic information and gene editing.

Risks related to our intellectual property, information technology and data security:

•Our ability to obtain, maintain and protect our intellectual property rights; and

•Our dependence on certain intellectual property rights that are licensed to us.

Risks related to litigation and our intellectual property:

•Our potential involvement in lawsuits in connection with intellectual property rights; and

13

Table of Contents

•Our ability to effectively protect and enforce our intellectual property rights.

Risks related to ownership of our Class A common stock:

•The multi-class structure of our common stock; and

•The requirement of our bylaws that the State of Delaware is the exclusive forum for substantially all disputes between us and our shareholders.

General risks:

•Our ability to meet our publicly announced guidance or other expectations about our business; and

•The volatility of the market price of our Class A common stock.

The summary risk factors described above should be read together with the text of the full risk factors below in this section titled “Risk Factors” and the other information set forth in this Annual Report on Form 10-K, including our consolidated financial statements and the related notes, as well as in other documents that we file with the SEC. The risks summarized above or described in full below are not the only risks that we face. Additional risks and uncertainties not precisely known to us or that we currently deem to be immaterial may also materially adversely affect our business, financial condition, results of operations and future prospects.

Risks related to our business and industry

Our operating results have in the past fluctuated significantly and may continue to fluctuate significantly in the future, which makes our future operating results difficult to predict and could cause our operating results